Search AI Products and News

Sarah Frueh, CFO of OpenAI, recently revealed at the Dublin Tech Summit that the company's ongoing organizational restructuring is paving the way for a possible initial public offering (IPO). Although OpenAI is actively preparing, whether it can successfully go public depends on both the company's own preparation and the overall atmosphere of the capital market. Image source note: Images generated by AI, images authorized service provider Midjourney. Frueh mentioned Microsoft's investment in OpenAI.

Researchers from Hong Kong and the UK have recently proposed a novel image tokenization method designed to convert images into digital representations (tokens) in a more compact and accurate manner. Unlike traditional methods that distribute information uniformly across all tokens, this method employs a hierarchical structure, capturing visual information layer by layer, thereby improving the quality and efficiency of image reconstruction. Traditional image tokenization techniques typically divide each part of an image equally into multiple tokens, whereas the new method adopts a hierarchical structure. Initial tokens encode rough shapes and structural elements,

AI is revolutionizing life sciences. Biocomputing company ProFluent recently launched ProGen3, a powerful generative protein language model (PLM) poised to drive breakthroughs in antibodies, industrial enzymes, and gene editing. Research shows ProGen3's scale and design optimizations enable the generation of highly functional novel proteins, potentially reshaping our understanding of biology. Proteins are vital molecules within living organisms, responsible for diverse physiological functions, from catalyzing reactions to recognition.

Artificial intelligence is rapidly transforming protein discovery and design in biotechnology. Recently, a collaborative team from UC Berkeley and Caltech developed ProteinDT, a novel multimodal framework leveraging text descriptions to aid in protein design. This innovative approach integrates protein sequence and structural information with a wealth of biological knowledge represented in text, opening a new chapter in protein design.

Recently, the world's first 'Humanoid Robot' Protoclone has garnered widespread attention on social media. This robot not only features an exquisite design but also possesses a muscle and skeletal structure, which is astonishing. In a captivating video, Protoclone hangs quietly on a frame, and as time passes, it begins to twitch and move, ultimately activating its limbs and displaying an extremely human-like posture. Protoclone was created by the tech startup Clone Robotic.

At the recent Qianfan Think Tank Life Sciences Forum, Baidu Smart Cloud launched the new biocomputing model tool HelixFold 3. This tool was co-developed by Baidu's PaddleHelix team and the CHPC High-Performance Computing Platform team, aiming to provide more accurate, efficient, and convenient solutions for life sciences research. The release of HelixFold 3 marks another technological breakthrough in the field of biocomputing. This model is particularly focused on RNA structure prediction and covalent modification.

In a personal investment note released on January 3, 2025, Zhou Yahui, Founder of Kunlun Wanwei, discussed the impact of the Robot Era on social structure. He pointed out that Kunlun Wanwei's mission is to gradually achieve General Artificial Intelligence (AGI) after 2030, with the aim of enabling everyone to better shape and express themselves. Zhou Yahui stated that despite numerous predictions about the realization of AGI both domestically and internationally, he firmly believes that AGI will gradually be realized starting in 2030, at which point robots will officially enter human society. Image source note: image generated by AI.

Recently, the artificial intelligence startup OpenAI stated in a blog post on its official website that, in face of its growing funding needs, the company urgently requires more funds to achieve its goals. This news has attracted widespread attention, as OpenAI has always operated as a nonprofit organization with the mission of 'building safe and beneficial general AI for the benefit of humanity.' With the rapid development of AI technology, OpenAI has realized that large enterprises are investing significantly in AI development in the current market.

A recent study suggests that artificial intelligence (AI) has the potential to surpass human intelligence in the future. The research delves into the complexities of AI and the human brain and proposes a new theoretical framework, indicating that by applying AI technology at the cellular level of neuroscience, AI could infinitely approach the functionality of the human brain, potentially even surpassing human intelligence levels. The human brain is widely regarded as one of the most complex systems in the universe, while artificial intelligence is seen as one of the most important technologies in human history. A core question looms: Will artificial intelligence ultimately surpass human intelligence?

AI drug development company Genesis Therapeutics recently announced that it has secured additional investment from Nvidia's venture capital arm, NVentures, though the specific amount remains undisclosed. This move marks a further deepening of the collaboration between the two parties, aimed at accelerating the development of Genesis's AI platform GEMS (Genesis Exploration of Molecular Space), which focuses on utilizing physics-based AI for structure-driven drug design.

Recently, a video has sparked widespread attention online, featuring an account impersonating Zhang Wenhong in a live stream selling a type of protein bar. Many netizens began to question, 'Is Zhang Wenhong really selling products?' Even more concerning is that some elderly viewers believed the video to be genuine, with some placing orders and sharing the information in social groups. After investigation, it was confirmed that the Zhang Wenhong in the video was not a real person, but a deepfake generated through AI technology. Zhang Wenhong has responded, indicating that there is more than one such fraudulent account.

Dutch and Swiss protein engineering AI startup Cradle recently announced the successful completion of a $73 million Series B funding round. This round was led by investment firm IVP, with participation from existing investors Index Ventures and Kindred Capital. So far, Cradle has raised over $100 million in total funding. Image source note: Image generated by AI and authorized by service provider Midjourney. Cradle is committed to

In the biotech field, leveraging artificial intelligence to accelerate research has become a new norm. Recently, biotech company Cradle announced it has completed a $73 million funding round, aiming to further expand its laboratories and team. Founded in 2022, Cradle is dedicated to exploring the applications of language models in biotechnology. Founder and CEO Stef van Grieken has vividly referred to the combinations of amino acids and bases as an 'alien programming language', although this language can also be processed by AI models.

Now, scientists can precisely "design" proteins as if they are programming. This is no longer science fiction but a reality being created by the Dutch company Cradle. In the grand tapestry of biotechnology, Cradle's founder, Stefan van Groningen, likens proteins to an "alien programming language." His team is utilizing artificial intelligence to decipher this mysterious language, bringing revolutionary changes to biotechnology. Traditional protein development has been like a long and costly blind exploration. Researchers must go through dozens of experimental rounds, each of which may...

Lumen Technologies is attempting to improve its financial situation by diversifying its business and restructuring its $20 billion debt through AI-related contracts. CFO Chris Stansbury acknowledges severe debt structure issues and has negotiated with creditors to obtain new credit lines and defer billions in maturing debt. The company focuses on AI connectivity services, recently securing a $5 billion contract with an additional $7 billion in po....

Google DeepMind has released AlphaProteo, an artificial intelligence system focused on generating novel proteins tailored to specific target molecules, aimed at accelerating drug design, disease understanding, and health application research. AlphaProteo successfully designed binders for the protein VEGF-A, which is associated with tumor growth and various disease complications, outperforming traditional methods. Unlike AlphaFold, the proteins designed by this system can interact with biological processes, providing possibilities for developing targeted therapies against harmful proteins.

AlphaSeq, launched by A-Alpha Bio, has broken the limitations of protein-protein interaction (PPI) prediction, becoming the world's largest PPI dataset with over 750 million measurement results. It contrasts the success of AlphaFold in protein structure prediction and excels particularly in PPI prediction, simplifying the process through innovative methods. The experimental platform of AlphaSeq efficiently measures the binding affinities of millions of PPIs, accelerating the pace of protein research. With expertise in computational biology...

Agently Workflow (hereinafter referred to as Agently) and LangGraph (hereinafter referred to as LangGraph) are two popular framework modules that exhibit distinct differences in terms of functionality, complex workflow propositions, and implementation solutions. This conclusion has sparked widespread discussion and attention in the industry. The recent comparative document points out that in some aspects of complex workflow orchestration and management, Agently possesses superior capabilities co

The artificial intelligence research lab EvolutionaryScale, founded by a former Meta engineer, recently launched ESM3, a biological design tool with native multimodality and generative language modeling.